Annual Report FY 2024-25
Indegene Limited (BSE: 544172, NSE: INDGN) is a digital-first life sciences commercialization company, enabling biopharmaceutical, emerging biotech, and medical device companies to develop, launch, and scale the impact of their products with greater speed, precision, and efficiency. As a specialized company, we combine healthcare domain expertise, fit-for-purpose technology, and an agile operating model to solve the most complex problems in the healthcare industry.
With over two decades of expertise and a robust technology backbone, we deliver tailored solutions across the commercialization value chain. Our integrated portfolio spans commercial, medical, regulatory, and R&D / Clinical operations of life sciences companies.
To enable healthcare organizations be future-ready
To be the trusted partner to healthcare organizations for improved health outcomes
Trust Empathy
Innovation Collaboration
Transform clinical trials by unlocking real-time patient insights, accelerating patient recruitment and enhancing data management to deliver innovative therapies faster
Communicate scientific information effectively, improve regulatory compliance, and manage safety operations efficiently across the enterprise
Build and connect brand strategy to omnichannel HCP and patient engagement using data and analytics across the enterprise and for specific brands
Data, Analytics, Technology 
Others
Enterprise Medical Solutions
Enterprise Commercial Solutions
Omnichannel Activation
